COVID-19 Phase IIb/III Vaccine Trial Synopsis
18 February 2020
| Publication
Overview
A randomized multi-center, blinded, control vaccine trial to evaluate the efficacy and safety of investigational vaccines for novel coronavirus disease (COVID-19) and infection.
The trial will be carried out under a Master Protocol to continue across outbreak sites until the scientific questions of interest are addressed.
WHO Team
R&D Blue Print (RDB)
Number of pages
6